文献速递肾小球疾病

膜性肾病治疗选择的思考

Membranous nephropathy: thinking through the therapeutic options.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

本文综述特发性膜性肾病(IMN)的治疗选择,强调需结合自然病史、病因识别及自身抗体/抗原系统数据,并整合预后不良指标与替代标志物,以更精准地选择现有治疗方案。

要点

  • 治疗前需评估典型IMN患者的自然病史、病因及自身抗体/抗原系统。
  • 结合预后不良指标与替代标志物可更精准选择治疗方案。
  • 现有治疗可延缓疾病进展,未来新疗法有望预防或逆转损伤。

核心结论

  • 整合自然病史、病因、自身抗体/抗原系统及预后标志物,可为IMN患者提供更合理精准的治疗选择。

研究设计与样本

  • 综述,未报告系统检索范围与样本量。

主要发现

  • IMN是成人肾病综合征最常见病因,也是终末期肾病可识别的主要病因之一。
  • 治疗前需考虑三个重要组成部分:典型患者自然病史、病因识别、自身抗体/抗原系统整合。
  • 结合预后不良指标与替代标志物可提供治疗计划正确的线索。

临床怎么用

  • 临床选择IMN治疗方案前应评估自然病史、病因及自身抗体/抗原系统。
  • 利用预后不良指标与替代标志物辅助判断治疗计划是否正确。

局限性

  • 原文未报告系统检索范围、样本量及具体数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Idiopathic membranous nephropathy (IMN) remains the most common cause of the nephrotic syndrome in adults and one of the leading identifiable causes of end-stage kidney disease. Prior to considering the best approach to treatment, three important components need to be considered. First, the natural history of the typical membranous patient today; second, the importance of identifying the causative factors; and third, the integration of the current data on the known autoantibody/antigen systems involved in IMN into the diagnosis and management of the patient. Combining this with information on the known indicators associated with a poor prognosis plus new data on surrogate markers that provide important clues that the treatment plan is correct has provided us with a more secure platform for choosing the right treatment for each patient. This already provides a more rational and precise approach to the use of our current therapeutic options. Even today, we can slow disease progression and in the future new approaches and new therapies are likely to lead to prevention of progression or even reversal of the injury in IMN, thereby leading to improved quality of life of our patients.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Cattran D, Brenchley P. Membranous nephropathy: thinking through the therapeutic options. Nephrol Dial Transplant. 2017. PMID: 28391348. doi:10.1093/ndt/gfw404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。